Abstract
In this paper we characterize the function of Xylosyltransferase 2 (XylT2) in different tissues to investigate the role XylT2 has in the proteoglycan (PG) biochemistry of multiple organs. The results show that in all organs examined there is a widespread and significant decrease in total XylT activity in Xylt2 knock out mice (Xylt2−/−). This decrease results in increased organ weight differences in lung, heart, and spleen. These findings, in addition to our previous findings of increased liver and kidney weight with loss of serum XylT activity, suggest systemic changes in organ function due to loss of XylT2 activity. The Xylt2−/− mice have splenomegaly due to enlargement of the red pulp area and enhanced pulmonary response to bacterial liposaccharide. Tissue glycosaminoglycan composition changes are also found. These results demonstrate a role of XylT2 activity in multiple organs and their PG content. Because the residual XylT activity in the Xylt2−/− is due to xylosyltransferase 1 (XylT1), these studies indicate that both XylT1 and XylT2 have important roles in PG biosynthesis and organ homeostasis.
Similar content being viewed by others
Abbreviations
- CS:
-
Chondroitin sulfate
- DMEM:
-
Dulbecco’s modified Eagle medium
- ECM:
-
extracellular matrix
- EDTA:
-
ethylenediaminetetracetic acid
- FITC:
-
fluorescein isothiocyanate
- GAG:
-
glycosaminoglycan
- HP:
-
heparin sulfate
- HS:
-
Heparan sulfate
- LPS:
-
bacterial lipopolysaccharide
- PAGE:
-
Polyacrylamide gel electrophoresis
- PBS:
-
phosphate-buffered saline
- PG:
-
proteoglycans
- RBCs:
-
red blood cells
- XylT2:
-
xylosyltransferase 2
- XylT1:
-
xylosyltransferase 1
References
Esko, J.D., Kimata, K., and Lindahl, U.: Proteoglycans and Sulfated Glycosaminoglycans. In: Essentials of glycobiology. pp. xxix, 784 p. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (2009)
Bernfield, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J., Zako, M.: Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729–777 (1999)
Esko, J.D., Selleck, S.B.: Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435–471 (2002)
Gustafsson, M., Boren, J.: Mechanism of lipoprotein retention by the extracellular matrix. Curr. Opin. Lipidol. 15(5), 505–514 (2004)
Mahley, R.W., Ji, Z.S.: Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40(1), 1–16 (1999)
Perrimon, N., Bernfield, M.: Specificities of heparan sulphate proteoglycans in developmental processes. Nature. 404(6779), 725–728 (2000)
Rosenberg, R.D., Shworak, N.W., Liu, J., Schwartz, J.J., Zhang, L.: Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 99(9), 2062–2070. (1997)
Hacker, U., Nybakken, K., Perrimon, N.: Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol. 6(7), 530–541 (2005)
Iozzo, R.V.: Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol. 6(8), 646–656 (2005)
Proudfoot, A.E., Handel, T.M., Johnson, Z., Lau, E.K., LiWang, P., Clark-Lewis, I., Borlat, F., Wells, T.N., Kosco-Vilbois, M.H.: Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100(4), 1885–1890 (2003)
Kearns, A.E., Vertel, B.M., Schwartz, N.B.: Topography of glycosylation and UDP-xylose production. J. Biol. Chem. 268(15), 11097–11104 (1993)
Stoolmiller, A.C., Horwitz, A.L., Dorfman, A.: Biosynthesis of the chondroitin sulfate proteoglycan. Purification and properties of xylosyltransferase. J Biol Chem. 247(11), 3525–3532 (1972)
Iozzo, R.V.: Proteoglycan Protocols. Humana Press, Totowa, NJ (2001)
Wilson, I.B.: The never-ending story of peptide O-xylosyltransferase. Cellular and molecular life sciences : CMLS. 61(7–8), 794–809 (2004). https://doi.org/10.1007/s00018-003-3278-2
Cuellar, K., Chuong, H., Hubbell, S.M., Hinsdale, M.E.: Biosynthesis of chondroitin and heparan sulfate in chinese hamster ovary cells depends on xylosyltransferase II. J. Biol. Chem. 282(8), 5195–5200 (2007). M611048200 [pii]). https://doi.org/10.1074/jbc.M611048200
Gotting, C., Kuhn, J., Zahn, R., Brinkmann, T., Kleesiek, K.: Molecular cloning and expression of human UDP-d-xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J. Mol. Biol. 304(4), 517–528 (2000). https://doi.org/10.1006/jmbi.2000.4261
Ponighaus, C., Ambrosius, M., Casanova, J.C., Prante, C., Kuhn, J., Esko, J.D., Kleesiek, K., Gotting, C.: Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans. J. Biol. Chem. 282(8), 5201–5206 (2007). https://doi.org/10.1074/jbc.M611665200
Voglmeir, J., Voglauer, R., Wilson, I.B.: XT-II, the second isoform of human peptide-O-xylosyltransferase, displays enzymatic activity. J. Biol. Chem. 282(9), 5984–5990 (2007). https://doi.org/10.1074/jbc.M608087200
Brunner, A., Kolarich, D., Voglmeir, J., Paschinger, K., Wilson, I.B.: Comparative characterisation of recombinant invertebrate and vertebrate peptide O-Xylosyltransferases. Glycoconj. J. 23(7–8), 543–554 (2006)
Esko, J.D., Elgavish, A., Prasthofer, T., Taylor, W.H., Weinke, J.L.: Sulfate transport-deficient mutants of Chinese hamster ovary cells. Sulfation of glycosaminoglycans dependent on cysteine. J Biol Chem. 261(33), 15725–15733 (1986)
Esko, J.D., Stewart, T.E., Taylor, W.H.: Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 82(10), 3197–3201 (1985)
Condac, E., Silasi-Mansat, R., Kosanke, S., Schoeb, T., Towner, R., Lupu, F., Cummings, R.D., Hinsdale, M.E.: Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 104(22), 9416–9421 (2007)
Munns, C.F., Fahiminiya, S., Poudel, N., Munteanu, M.C., Majewski, J., Sillence, D.O., Metcalf, J.P., Biggin, A., Glorieux, F., Fassier, F., Rauch, F., Hinsdale, M.E.: Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects. Am. J. Hum. Genet. 96(6), 971–978 (2015). https://doi.org/10.1016/j.ajhg.2015.04.017
Taylan, F., Costantini, A., Coles, N., Pekkinen, M., Heon, E., Siklar, Z., Berberoglu, M., Kampe, A., Kiykim, E., Grigelioniene, G., Tuysuz, B., Makitie, O.: Spondyloocular syndrome: novel mutations in XYLT2 gene and Expansion of the phenotypic Spectrum. J. Bone Miner. Res. 31(8), 1577–1585 (2016). https://doi.org/10.1002/jbmr.2834
Guleray, N., Simsek Kiper, P.O., Utine, G.E., Boduroglu, K., Alikasifoglu, M.: Intrafamilial variability of XYLT2-related spondyloocular syndrome. Eur J Med Genet. 62(11), 103585 (2019). https://doi.org/10.1016/j.ejmg.2018.11.019
Taylan, F., Yavas Abali, Z., Jantti, N., Gunes, N., Darendeliler, F., Bas, F., Poyrazoglu, S., Tamcelik, N., Tuysuz, B., Makitie, O.: Two novel mutations in XYLT2 cause spondyloocular syndrome. Am. J. Med. Genet. A. 173(12), 3195–3200 (2017). https://doi.org/10.1002/ajmg.a.38470
Umair, M., Eckstein, G., Rudolph, G., Strom, T., Graf, E., Hendig, D., Hoover, J., Alanay, J., Meitinger, T., Schmidt, H., Ahmad, W.: Homozygous XYLT2 variants as a cause of spondyloocular syndrome. Clin. Genet. 93(4), 913–918 (2018). https://doi.org/10.1111/cge.13179
Gotting, C., Kuhn, J., Kleesiek, K.: Human xylosyltransferases in health and disease. Cellular and molecular life sciences : CMLS. 64(12), 1498–1517 (2007). https://doi.org/10.1007/s00018-007-7069-z
Condac, E., Dale, G.L., Bender-Neal, D., Ferencz, B., Towner, R., Hinsdale, M.E.: Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum. Glycobiology. 19(8), 829–833 (2009). cwp058 [pii]). https://doi.org/10.1093/glycob/cwp058
Pfeil, U., Wenzel, K.W.: Purification and some properties of UDP-xylosyltransferase of rat ear cartilage. Glycobiology. 10(8), 803–807 (2000)
Fisher, L.W., Stubbs 3rd, J.T., Young, M.F.: Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. 266, 61–65 (1995)
Brown, A.H.: Determination of pentose in the presence of large quantities of glucose. Arch. Biochem. 11, 269–278 (1946)
Ledin, J., Staatz, W., Li, J.P., Gotte, M., Selleck, S., Kjellen, L., Spillmann, D.: Heparan sulfate structure in mice with genetically modified heparan sulfate production. J. Biol. Chem. 279(41), 42732–42741 (2004)
Warda, M., Toida, T., Zhang, F., Sun, P., Munoz, E., Xie, J., Linhardt, R.J.: Isolation and characterization of heparan sulfate from various murine tissues. Glycoconj. J. 23(7–8), 555–563 (2006)
Bruckner, J.: Estimation of monosaccharides by the orcinol-sulphuric acid reaction. Biochem. J. 60(2), 200–205 (1955)
Lawrence, R., Olson, S.K., Steele, R.E., Wang, L., Warrior, R., Cummings, R.D., Esko, J.D.: Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling. J. Biol. Chem. 283(48), 33674–33684 (2008)
Roch, C., Kuhn, J., Kleesiek, K., Gotting, C.: Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans. Biochem. Biophys. Res. Commun. 391(1), 685–691 (2010). https://doi.org/10.1016/j.bbrc.2009.11.121
Sivasami, P., Poudel, N., Munteanu, M.C., Hudson, J., Lovern, P., Liu, L., Griffin, T., Hinsdale, M.E.: Adipose tissue loss and lipodystrophy in xylosyltransferase II deficient mice. Int. J. Obes. 43, 1783–1794 (2019). https://doi.org/10.1038/s41366-019-0324-1
Hallgren, O., Nihlberg, K., Dahlback, M., Bjermer, L., Eriksson, L.T., Erjefalt, J.S., Lofdahl, C.G., Westergren-Thorsson, G.: Altered fibroblast proteoglycan production in COPD. Respir. Res. 11, 55 (2010)
van Straaten, J.F., Coers, W., Noordhoek, J.A., Huitema, S., Flipsen, J.T., Kauffman, H.F., Timens, W., Postma, D.S.: Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod. Pathol. 12(7), 697–705 (1999)
O'Brien, K., Font-Montgomery, E., Lukose, L., Bryant, J., Piwnica-Worms, K., Edwards, H., Riney, L., Garcia, A., Daryanani, K., Choyke, P., Mohan, P., Heller, T., Gahl, W.A., Gunay-Aygun, M.: Congenital hepatic fibrosis and portal hypertension in autosomal dominant polycystic kidney disease. J. Pediatr. Gastroenterol. Nutr. 54(1), 83–89 (2012)
Park, P.W.: Introduction to the thematic mini-review series on "matrix biology in lung health and disease". Matrix Biol. 73, 1–5 (2018). https://doi.org/10.1016/j.matbio.2018.07.002
Chignalia, A.Z., Yetimakman, F., Christiaans, S.C., Unal, S., Bayrakci, B., Wagener, B.M., Russell, R.T., Kerby, J.D., Pittet, J.F., Dull, R.O.: The Glycocalyx and trauma: a review. Shock. 45(4), 338–348 (2016). https://doi.org/10.1097/SHK.0000000000000513
Sivasami, P., Poudel, N., Munteanu, M.C., Hudson, J., Lovern, P., Liu, L., Griffin, T., Hinsdale, M.E.: Adipose tissue loss and Lipodystrophy in Xylosyltransferase II deficient mice. International Journal of Obesity (Accepted).
Acknowledgements
This work was supported by Oklahoma Center for Advancement of Science and Technology, Oklahoma Center for Adult Stem Cell Research, and National Institutes of Health DK087989. We are thankful to the University of California at San Diego’s Glycoanalytics Core facility as well for expertise in disaccharide analyses. We are also very thankful for the helpful statistical advice of Ms. Binu Sharma.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interests.
Ethical approval
All mice were housed in facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International: The Institutional Animal Care and Use Committees of all institutions approved all animal procedures and experiments.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ferencz, B., Condac, E., Poudel, N. et al. Xylosyltransferase 2 deficiency and organ homeostasis. Glycoconj J 37, 755–765 (2020). https://doi.org/10.1007/s10719-020-09945-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-020-09945-9